Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery is a research paper published in Molecular Therapy — Methods & Clinical Development (2020). On theSindex it has a DataRank of 0. It has been cited 87 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HL130856
National Heart, Lung, and Blood Institute
Grant: HL135853
National Heart, Lung, and Blood Institute
Grant: HL148681
National Heart, Lung, and Blood Institute
Grant: NNJ16ZSA001N-TRIRT
NHLBI NIH HHS
Grant: R01 HL130856
NHLBI NIH HHS
Grant: U01 HL148681
NHLBI NIH HHS
Grant: R01 HL135853
National Institutes of Health
Grant: 1U01HL148681-01
cGMP Manufacture Of FVIII-Expressing Placental Cells For Hemophilia A
National Institutes of Health
Grant: 5R01HL135853-02
Prenatal Cell and Gene Therapy for Hemophilia A
National Institutes of Health
Grant: 1R01HL130856-01A1
Postnatal Cell-Based Therapies for Hemophilia A
National Institutes of Health
National Aeronautics and Space Administration
FWCI
6.29
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals